Blog

Juno Therapeutics, Thermo Fisher ink partnership deal to manufacture CAR-T therapies – FiercePharma


FiercePharma

Juno Therapeutics, Thermo Fisher ink partnership deal to manufacture CART therapies
FiercePharma
The beads activate and expand T cells that have been genetically engineered to recognize and fight cancer cells in each individual patient. Financial terms of the deal weren't disclosed. CAR-T drugs are made of a patient's own cells that are removed
Thermo Fisher Scientific agrees manufacturing deal with Juno TherapeuticsZenopa



all 47 news articles »

2017-12-21 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.